PHARMBIOTRAC SUSTAINABILITY WORRY! Shs29bn Traditional Medicine Centre Project Investment at Risk as MUST Fails to Secure Gains
The Auditor General has raised concerns regarding the sustainability of the PHARMBIOTRAC project at Mbarara University of Science and Technology. Despite significant investment, the university has failed to implement adequate measures to maintain the project's research and innovation gains.
Why it matters
The potential waste of millions of dollars in public and international funding threatens the future of regional drug development and traditional medicine research.
MBARARA — Questions have been raised over the future of the Pharmbiotechnology and Traditional Medicine Centre (PHARMBIOTRAC) at Mbarara University of Science and Technology (MUST) after the Auditor General found that the university had not put in place adequate measures to sustain the benefits achieved under the project.
The audit warned that failure to consolidate and maintain the gains made during the project lifetime could result in public funds invested in the initiative being put to waste.
The finding comes after millions of dollars were invested in the project to strengthen human capital development, research and innovation in pharm-biotechnology and traditional medicine.
The Auditor General noted that the university had not put in place adequate sustainability measures to consolidate and maintain the benefits achieved during the project lifetime and avoid putting to waste all funds invested in the project.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in